(I-1C.O) 57-year-old patient with a coronary arteries anomaly Monika Smaś-Suska MD, Lidia Tomkiewicz-Pająk MD, PhD, Assoc. Prof. Piotr Musiałek MD, PhD, Natalia Dłużniewska MD, Prof. Maria Olszowska MD, PhD, Prof. Piotr Podolec MD, PhD
EXPERTISE 1 EXPERTISE 2 “Development of the European Network in Orphan Cardiovascular Diseases” “Rozszerzenie Europejskiej Sieci Współpracy ds. Sierocych Chorób Kardiologicznych”
(II-1C.O) What is the coincidence of pulmonary arterial hypertension associated with congenital cardiac shunt and hypertrophic cardiomyopathy in patient with trisomy 21 Wojciech Wróbel MD, PhD, Prof.Katarzyna Mizia-Stec MD, PhD
BRIEF COMMENTS EXPERT: Prof. Janusz Skalski MD, PhD Affiliation: Department of Pediatric Cardiac Surgery, Jagiellonian University Medical College, Krakow COMMENT Diagnosis of cardiomyopathy needs closer evaluation. Ventricular hypertrophy and pulmonary arterial hypertension might be consequences of congenital heart defect, not necessarily cardiomyopathy. It is not clear why the patient wasn’t operated in the past? EXPERT: Prof. Katarzyna Mizia-Stec MD, PhD Affiliation: 1st Department of Cardiology, Medical University of Silesia, Katowice,Poland COMMENT Ventricle hypertrophy was first noticed in 2005. Question …
(I-1C.O) 28 -year – old man with anomalous origin of the right coronary artery from the ascending aorta. Sylwia Wiśniowka-Śmiałek MD, Agata Leśniak-Sobelga MD, Paweł Rubiś MD, Ph.D, Maciej Krupiński MD.
Background Coronary artery anomalies (CAAs) are a diverse group of congenital malformations, which clinical manifestations and pathology are highly variable . Being rare, they are recognized cause of myocardial ischemia and occasionally sudden cardiac death . The frequency of anomalous aortic origin of the coronary arteries is noted in 0,6 to 1,2 % of patients (based on coronary angiography), with significant higher incidence in young victims of sudden cardiac death in comparison to adults (4-15% versus 1% respectively). There is …